Sudeep Pharma Limited (SUDEEPPHRM)
Chemicals · Chemicals & Petrochemicals · NSE
· Updated 15 July 2026
₹837.45
Market Cap
₹7,330
Div Yield
0.00%
Promoter
0.0%
⚖️ Peer Comparison — Chemicals & Petrochemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| Solar Industries India Limited | 1.57 L Cr | 132.3 | — | — | — |
| Pidilite Industries Limited | 1.49 L Cr | 75.7 | — | — | — |
| SRF Limited | 79,723 | 69.5 | — | — | — |
| Linde India Limited | 62,701 | 141.9 | — | — | — |
| Gujarat Fluorochemicals Limited | 40,793 | 89.6 | — | — | — |
| Navin Fluorine International Limited | 35,894 | 131.5 | — | — | — |
| Himadri Speciality Chemical Limited | 30,071 | 56.6 | — | — | — |
| Deepak Nitrite Limited | 24,911 | 33.3 | — | — | — |
| Atul Limited | 20,904 | 48.8 | — | — | — |
| Tata Chemicals Limited | 19,079 | -47.1 | — | — | — |
🔗 Peer Stock Analyses
📋 Recent Filings
-
🔴 Corporate Action 10 July 2026Sudeep Pharma announced a final dividend of ₹1.50 per share for FY 2025-26, with the record date set for 23 July 2026 to determine entitlement ahead o...
-
🟡 Board Meeting 26 June 2026Sudeep Pharma announced the appointment of Mr. Milin Mehta as an additional non-executive non-independent director effective 26 June 2026, pending sha...
-
🟡 Board Meeting 26 June 2026Sudeep Pharma announced the appointment of Mr. Milin Mehta as a Non-Executive Non-Independent Director effective 26 June 2026, following shareholder a...
-
Announcement 21 May 2026Sudeep Pharma Limited reported FY26 revenue of **₹642.3 crores**, up 16% YoY, with PAT rising to **₹174.3 crores** (27.1% margin) and EPS at **₹12.79*...
-
🔴 Corporate Action 21 May 2026Sudeep Pharma Limited announced a final dividend of Rs 1.50 per share (150% of face value) for FY2025-26, approved by its board on 21 May 2026, pendin...
-
🟡 Board Meeting 21 May 2026Sudeep Pharma Limited announced the outcome of its 21 May 2026 board meeting, approving audited standalone and consolidated financial results for the ...
-
share transfer 10 April 2026Sudeep Pharma Limited received a Regulation 74(5) certificate from its share transfer agent confirming no demat requests were processed during Q1 2026...
-
🔴 Announcement 8 April 2026Sudeep Pharma Limited disclosed a mandatory acquisition announcement under SEBI Takeover Regulations on **April 8, 2026**. The filing involves a poten...
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.
📡 Get AI alerts when SUDEEPPHRM files new disclosures
Track SUDEEPPHRM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SUDEEPPHRM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research